PATENT CLAIM ANALYSIS

Application Number: 15755390
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "217010"]

Abstract:
The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.

Claim (Index 7):
Compounds for the use according to any one of the preceding claims, wherein the immune-inflammatory diseases are selected from multiple sclerosis, rheumatoid arthritis, Crohn's disease, psoriasis, psoriatic arthritis, inflammatory bowel disease (IBD), ulcerative colitis (UC), systemic lupus erythematosus (SLE), Sjogren syndrome, ANCA-induced vasculitis, ankylosing spondylitis, anti-phospholipid syndrome, myasthenia gravis, Addison's disease, alopecia areata, ankylosing spondylitis, antiphospholipid antibody syndrome, antiphospholipid syndrome (primary or secondary), asthma, autoimmune gastritis, autoimmune hemolytic anemia, autoimmune hepatitis, autoimmune inner ear disease, autoimmune lymphoproliferative disease, autoimmune thrombocytopenic purpura, Balo disease, Behcet's disease, bullous pemphigoid, cardiomyopathy, celiac disease, Chagas disease, chronic inflammatory demyelinating polyneuropathy, cicatrical pemphigoid, cold agglutinin disease, degos disease, dermatitis hepatiformis, essential mixed cryoglobulinemia, Goodpasture's syndrome, Graves' disease, Guillain-Barre syndrome, Hashimoto's thyroiditis, idiopathic pulmonary fibrosis, idiopathic thrombocytopenia purpura, IgA nephropathy, juvenile arthritis, lichen planus, Meniere disease, mixed connective tissue disease, morephea, neuromyotonia, pemphigus vulgaris, pernicious anemia, polyarteritis nodosa, polychondritis, polymyalgia rheumatica, primary agammaglobulinemia, primary biliary cirrhosis, Raynaud disease (Raynaud phenomenon), Reiter's syndrome, relapsing polychondritis, rheumatic fever, Sjogren's syndrome, stiff-person syndrome (Moersch-Woltmann syndrome), Takayasu's arteritis, temporal arteritis (giant cell arteritis), uveitis, vasculitis, vitiligo, Wegener's granulomatosis and/or neuromyelitis optica, isolated CNS-vasculitis.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11901843', '09886773', '12786221', '11801473', '13567146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7711196373575847
- 35 USC 102 Novelty (BERT): 0.497443972184411
- Combined Prediction Score: 0.7437520708402674
- Mean Citation Score: 226.707182
- Max Citation Score: 232.65176
- Similarity Product: 166.64357694480896

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test